MTOR and cancer: Mammalian target of rapamycin (mTOR) inhibitors have several properties that may be especially beneficial in xenotransplantation, e.g., suppression of T cell proliferation, increases in the number of T regulatory cells, inhibition of pig graft growth, and anti-inflammatory, anti-viral, and anti-cancer effects [132].